Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2010 07:34 ET | Source: Cannabis Science, Inc.

Cannabis Science President and CEO Dr. Robert Melamede, PhD., Files Preliminary Patent Disclosures With the University of Colorado Regarding New Technology That Cannabis Science Intends to Develop Through a Private Company Acquisition

COLORADO SPRINGS, Colo., June 1, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announces...
May 25, 2010 14:05 ET | Source: Cannabis Science, Inc.

Cannabis Reports on Bloomberg News, 15 Members of Congress Led by Representative Barney Frank Support Dispensaries as Legitimate Businesses; Cannabis Science Value Increased for Pharmaceutical Research and Development; New Colorado Law Adds Protection

COLORADO SPRINGS, Colo., May 25, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is very pleased to report...
May 24, 2010 06:00 ET | Source: Cannabis Science, Inc.

Cannabis Science Acquires Two Revenue Producing Operations, a Medical Marijuana Growing Facility and a Dispensary to Facilitate Operational Growth, Research and Development of Pharmaceutical Cannabis Products in Colorado in Accordance With State Laws

COLORADO SPRINGS, Colo., May 24, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce...
May 20, 2010 13:21 ET | Source: Cannabis Science, Inc.

Cannabis Science Identifies Another Urgent Need for Its Pharmaceutical Products as Suicides and Sudden Deaths Among Vets With Post Traumatic Stress Disorder Linked to a Number of Widely-Prescribed FDA Approved Pharmaceuticals Such as Seroquel and Other Antipsychotics, Antidepressants, Mood Stabilizers, Sleep Inducers, Pain, and Seizure Medications

COLORADO SPRINGS, Colo., May 20, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, notes with great sadness...
May 19, 2010 11:14 ET | Source: Cannabis Science, Inc.

Cannabis Science Comments on Recent USA TODAY Article That The Obama Administration Refocuses Its Unsuccessful War On Drugs to a Public Health Fight and Speaks About the Growing Recognition of Marijuana for Medical Purposes

COLORADO SPRINGS, Colo., May 19, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce...
May 13, 2010 10:24 ET | Source: Cannabis Science, Inc.

Cannabis Science Negotiates for a 7,500 Sq. Ft., Facility in Colorado Springs to Facilitate Both Research and Revenues in the Company's Five Divisions

COLORADO SPRINGS, Colo., May 13, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce it is...
May 12, 2010 14:44 ET | Source: Cannabis Science, Inc.

Cannabis Science Inc. Adds Online Communication Specialists in Response to an Increasing Interest in Dr. Robert Melamede's Understanding of the Amazing Role Played by the Endocannabinoid System Worldwide

COLORADO SPRINGS, Colo., May 12, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased to announce...
May 07, 2010 10:26 ET | Source: Cannabis Science, Inc.

Cannabis Science New Management Files First 10K Annual Report, Opens In-House Investor Relations Department in Southern Florida, and Prepares to Announce Several Expansions and Advancements for Each of Its Divisions

COLORADO SPRINGS, Colo., May 7, 2010 (GLOBE NEWSWIRE) -- Cannabis Science, Inc. (OTCBB:CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that...
April 12, 2010 11:35 ET | Source: Cannabis Science, Inc.

Dr. Robert Melamede, PhD., President & CEO of Cannabis Science, Reports High Level of Media Interest in Public Speaking Engagements, News Interviews, and Corporate Sponsorships at Several Cannabis Related Events Over the Next Few Weeks; Beginning in Denver Last Weekend; in Rhode Island This Week; Focusing on the Science of Bringing Cannabis Medicines to Our Patients Through the FDA Process

COLORADO SPRINGS, Colo., April 12, 2010 (GLOBE NEWSWIRE) -- Dr. Robert Melamede, CEO and President of Cannabis Science, Inc. (OTCBB:CBIS), a pioneering U.S. biotech company developing pharmaceutical...
March 31, 2010 14:33 ET | Source: Cannabis Science, Inc.

Cannabis Science Calls for Public Support for Vets as New York Times Reports VA Docs Prohibited From "Recommending" Cannabis for Post Traumatic Stress Disorder (PTSD)

Colorado Bureaucrats and Politicians Just Say No to Vets Should 20 Year-Old Disabled Vet Have to Go to "Substance Abuse Counselor" Before Getting Medical Marijuana? COLORADO SPRINGS, Colo.,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right